UA93530C2 - Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения - Google Patents
Композиция c пролонгированным высвобождением активного вещества, способ ee получения и примененияInfo
- Publication number
- UA93530C2 UA93530C2 UAA200808585A UAA200808585A UA93530C2 UA 93530 C2 UA93530 C2 UA 93530C2 UA A200808585 A UAA200808585 A UA A200808585A UA A200808585 A UAA200808585 A UA A200808585A UA 93530 C2 UA93530 C2 UA 93530C2
- Authority
- UA
- Ukraine
- Prior art keywords
- active ingredient
- composition
- sustained release
- preparation
- esters
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Фармацевтическая, нутрицевтическая или ветеринарная композиция, которая содержит, по меньшей мере, одну гранулу, покрытую оболочкой, с пролонгированным высвобождением активного вещества, причем указанная гранула, покрытая оболочкой, состоит из частицы, содержащей указанное активное вещество, покрытое, по меньшей мере, двумя оболочками, содержащими комбинацию эксципиентов, которая состоит из, по меньшей мере, одного сополимера (а) сложных эфиров акриловой кислоты и метакриловой кислоты, в котором молярное содержание групп четвертичного аммония ниже или равно 8 %, в ассоциации со вторым сополимером (b) сложных эфиров акриловой кислоты и метакриловой кислоты, в котором молярное содержание групп четвертичного аммония выше 8 %, в массовом соотношении (а)/(b), который составляет от 60/40 до 80/20, и при
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0512189A FR2894143B1 (fr) | 2005-12-01 | 2005-12-01 | Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation. |
Publications (1)
Publication Number | Publication Date |
---|---|
UA93530C2 true UA93530C2 (ru) | 2011-02-25 |
Family
ID=36968738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200808585A UA93530C2 (ru) | 2005-12-01 | 2006-11-23 | Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения |
Country Status (27)
Country | Link |
---|---|
US (1) | US8834923B2 (ru) |
EP (1) | EP1954251B1 (ru) |
JP (1) | JP5674275B2 (ru) |
KR (1) | KR101332744B1 (ru) |
CN (1) | CN101321520A (ru) |
AR (1) | AR057212A1 (ru) |
AT (1) | ATE548030T1 (ru) |
AU (1) | AU2006319077B2 (ru) |
BR (1) | BRPI0619774B1 (ru) |
CA (1) | CA2632547C (ru) |
DK (1) | DK1954251T3 (ru) |
ES (1) | ES2383760T3 (ru) |
FR (1) | FR2894143B1 (ru) |
IL (1) | IL191758A (ru) |
MA (1) | MA29770B1 (ru) |
NO (1) | NO339720B1 (ru) |
NZ (1) | NZ566783A (ru) |
PL (1) | PL1954251T3 (ru) |
PT (1) | PT1954251E (ru) |
RS (1) | RS52308B (ru) |
RU (1) | RU2414211C2 (ru) |
SI (1) | SI1954251T1 (ru) |
TN (1) | TNSN08152A1 (ru) |
TW (1) | TWI374035B (ru) |
UA (1) | UA93530C2 (ru) |
WO (1) | WO2007063200A1 (ru) |
ZA (1) | ZA200801896B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0613583D0 (en) * | 2006-07-05 | 2006-08-16 | Sericol Ltd | A printing ink |
CN101912049A (zh) * | 2010-07-27 | 2010-12-15 | 广州市正百饲料科技有限公司 | 包被微量元素预混料及其制备方法 |
CN103191078B (zh) * | 2012-01-06 | 2018-01-09 | 常州善美药物研究开发中心有限公司 | 一种双膜多药层的高溶解度盐类药物控释片 |
NL2014348B1 (en) | 2015-02-25 | 2016-10-13 | Univ Delft Tech | Controlled release from particles encapsulated by molecular layer deposition. |
RU2702690C2 (ru) * | 2015-08-13 | 2019-10-09 | БИОЛИНГУС АйПи ЛЛСи | Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые |
RU2616264C1 (ru) * | 2016-03-28 | 2017-04-13 | Санкт-Петербургское Государственное бюджетное учреждение здравоохранения "Родильный дом N 10" | Способ профилактики железодефицитной анемии у несовершеннолетних беременных женщин |
RU2623071C1 (ru) * | 2016-09-29 | 2017-06-21 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Лечебно-профилактический хелатный железосодержащий препарат для сельскохозяйственных животных |
CN106344534B (zh) * | 2016-09-30 | 2019-07-19 | 广西科技大学 | 硫酸亚铁肠溶滴丸的制备方法 |
WO2019097400A1 (en) * | 2017-11-14 | 2019-05-23 | Greem Pharm S.R.L. | Oral administration form comprising an iron-copper mixture and its use as a food supplement |
CN109999058A (zh) * | 2019-05-22 | 2019-07-12 | 江阴天江药业有限公司 | 一种胶类中药的烊化方法和产品,以及由该产品制得的固体饮料及其制备方法 |
WO2024006539A1 (en) * | 2022-07-01 | 2024-01-04 | Vitakey Inc. | Nutraceutical particles |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3622487A1 (de) * | 1986-07-02 | 1988-01-14 | Schering Ag | Arzneimittel mit verzoegerter wirkstoffabgabe |
IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5478577A (en) | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
DE4332394A1 (de) * | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
FR2792527B1 (fr) * | 1999-04-22 | 2004-08-13 | Ethypharm Lab Prod Ethiques | Microgranules de ketoprofene, procede de preparation et compositions pharmaceutiques |
CN1202815C (zh) * | 1999-08-31 | 2005-05-25 | 格吕伦塔尔有限公司 | 含有曲马朵糖精盐的持续释放给药剂型 |
RU2292877C2 (ru) * | 1999-08-31 | 2007-02-10 | Грюненталь Гмбх | Лекарственная ретард-форма, содержащая сахаринат трамадола |
AU783656B2 (en) * | 1999-09-02 | 2005-11-24 | Nostrum Pharmaceuticals, Inc. | Controlled release oral dosage suitable for oral administration |
SK287684B6 (sk) | 1999-12-20 | 2011-06-06 | Schering Corporation | Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
EA200201044A1 (ru) * | 2000-03-31 | 2003-04-24 | Нюкомед Аустриа Гмбх | Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин |
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
KR100477874B1 (ko) | 2001-04-10 | 2005-03-22 | 곽해수 | 지방산에스터를 이용한 수용성 철분 미세캡슐 |
JP2005506323A (ja) * | 2001-09-05 | 2005-03-03 | ベクトゥラ・リミテッド | 経口送達用機能性散剤 |
EP1474123A1 (en) | 2002-01-03 | 2004-11-10 | LEK Pharmaceuticals D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
US20030190355A1 (en) * | 2002-04-05 | 2003-10-09 | Hermelin Marc S. | Modified release minerals |
DK1542658T3 (da) * | 2002-08-15 | 2011-04-04 | Euro Celtique Sa | Farmaceutiske sammensætninger omfattende et opioidanalgetikum |
US6562378B1 (en) * | 2002-08-16 | 2003-05-13 | Tsar Health Private Ltd. | Nutritional supplement for adolescents |
BRPI0413927B8 (pt) * | 2003-08-29 | 2021-05-25 | Lifecycle Pharma As | composição farmacêutica compreendendo tacrolimus, forma de dosagem, uso da composição, e, método para a preparação da composição |
-
2005
- 2005-12-01 FR FR0512189A patent/FR2894143B1/fr active Active
-
2006
- 2006-11-23 RS RS20120229A patent/RS52308B/en unknown
- 2006-11-23 KR KR1020087008548A patent/KR101332744B1/ko active IP Right Grant
- 2006-11-23 NZ NZ566783A patent/NZ566783A/en unknown
- 2006-11-23 PL PL06831163T patent/PL1954251T3/pl unknown
- 2006-11-23 RU RU2008126728/15A patent/RU2414211C2/ru active
- 2006-11-23 UA UAA200808585A patent/UA93530C2/ru unknown
- 2006-11-23 ES ES06831163T patent/ES2383760T3/es active Active
- 2006-11-23 PT PT06831163T patent/PT1954251E/pt unknown
- 2006-11-23 SI SI200631341T patent/SI1954251T1/sl unknown
- 2006-11-23 WO PCT/FR2006/002577 patent/WO2007063200A1/fr active Application Filing
- 2006-11-23 AU AU2006319077A patent/AU2006319077B2/en active Active
- 2006-11-23 DK DK06831163.8T patent/DK1954251T3/da active
- 2006-11-23 US US12/085,501 patent/US8834923B2/en active Active
- 2006-11-23 EP EP06831163A patent/EP1954251B1/fr active Active
- 2006-11-23 JP JP2008542790A patent/JP5674275B2/ja active Active
- 2006-11-23 AT AT06831163T patent/ATE548030T1/de active
- 2006-11-23 CA CA2632547A patent/CA2632547C/fr active Active
- 2006-11-23 CN CNA2006800453522A patent/CN101321520A/zh active Pending
- 2006-11-23 BR BRPI0619774-4A patent/BRPI0619774B1/pt active IP Right Grant
- 2006-11-30 TW TW095144284A patent/TWI374035B/zh active
- 2006-12-01 AR ARP060105306A patent/AR057212A1/es not_active Application Discontinuation
-
2008
- 2008-02-28 ZA ZA200801896A patent/ZA200801896B/xx unknown
- 2008-03-07 MA MA30732A patent/MA29770B1/fr unknown
- 2008-04-02 TN TNP2008000152A patent/TNSN08152A1/fr unknown
- 2008-04-29 NO NO20082047A patent/NO339720B1/no unknown
- 2008-05-27 IL IL191758A patent/IL191758A/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA93530C2 (ru) | Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения | |
ATE553754T1 (de) | Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser | |
WO2007006353A3 (de) | Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten | |
DE50107641D1 (de) | Überzugs- und bindemittel für arzneimittelformulierungen mit verbesserter lagerstabilität | |
BRPI0620185B8 (pt) | formulação farmacêutica, comprimidos, e, processo para a preparação de uma formulação farmacêutica | |
WO2005079748A3 (en) | Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient | |
AU6197499A (en) | Coated medicament forms with controlled active substance release | |
WO2015120110A3 (en) | Novel pharmaceutical formulations | |
WO2010015665A3 (en) | Parenteral composition comprising microspheres with a diameter between 10 and 20 microns | |
WO2009063222A3 (en) | Solid compositions | |
NZ589017A (en) | Solid pharmaceutical formulation with delayed release | |
WO2012085043A3 (en) | Rapidly disintegrating, solid coated dosage form | |
IL174830A0 (en) | Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation | |
MX2013014142A (es) | Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol. | |
TW200635963A (en) | Partially neutralized anionic (meth)acrylate copolymer | |
NZ595061A (en) | Formulation comprising avermectin particles coated with a photo - protecting agent | |
WO2007022022A3 (en) | Volumizing agents | |
MX2015010449A (es) | Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos. | |
MX2010007578A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa. | |
MX2010007579A (es) | Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada. | |
NZ535750A (en) | Film coating for controlled release of pharmaceutical drugs | |
PL1694320T3 (pl) | Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności | |
PL1815850T3 (pl) | Preparat kwasu diwalproinowego i jego pochodnych do kontrolowanego uwalniania | |
WO2010003465A3 (en) | A drug powder for inhalation administration and a process thereof | |
WO2011159491A3 (en) | Controlled release levetiracetam formulations |